Vanessa Q. Passos

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg et al. · Nature Medicine · 2023 · 252 citations · Full text

ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non–Small Cell Lung Cancer (NSCLC)

Byoung Chul Cho, Dong‐Wan Kim, Alessandra Bearz et al. · Journal of Thoracic Oncology · 2017 · 169 citations · Full text

Fasted State, Randomized Phase 1, Medicine +10

Long-Term Follow-Up of Prolactinomas: Normoprolactinemia after Bromocriptine Withdrawal

Vanessa Q. Passos, Jean Jorge Silva de Souza, Nina Rosa Castro Musolino et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 107 citations · Full text

Surgical Oncology, Medicine, Serum Prolactin +12

Systemic hypertension, diabetes mellitus, and dyslipidemia in relation to body mass index: evaluation of a Brazilian population

Cíntia Cercato, Márcio C. Mancini, Ana Maria Carvalho Arguello et al. · Revista do Hospital das Clínicas · 2004 · 93 citations · Full text

Genes Differentially Expressed in Prolactinomas Responsive and Resistant to Dopamine Agonists

Vanessa Q. Passos, Maria Angela Henriques Zanella Fortes, Daniel Giannella‐Neto et al. · Neuroendocrinology · 2008 · 74 citations